HIV Diagnosis Market Size, Share, Development, Growth and Demand Forecast to 2023

1
Global HIV Diagnosis Market to Witness 10.6 CAGR
during 2017 2023
2
Global HIV Diagnosis Market
According to a new market research report Global
HIV Diagnosis Market Size, Share, Development,
Growth and Demand Forecast to 2023 - Industry
Insight by Product (Consumables, Instruments and
Software Services), by Type of Test (Antibody
Test, Viral Load, CD4, Early Infant Diagnosis and
Viral Identification), by End User (Diagnostic
Laboratories, Hospitals, Research Institutes and
Others) published by PS Market Research, the
global HIV diagnosis market is expected to grow
at a CAGR of 10.6, during 2017 - 2023. Browse
Report Description at https//www.psmarketresearc
h.com/market-analysis/hiv-diagnosis-market
3
Global HIV Diagnosis Market
Increasing prevalence of HIV/AIDS drives the
global market
According to the study, the global HIV diagnosis
market is likely to grow significantly during the
forecast period, due to rising prevalence of
HIV/AIDS, growing awareness leading to high
number of blood donations and blood transfusions,
and advantageous features of point of care
instruments and kits. In addition, rising
healthcare expenditure on HIV and related
activities further contributes to the growth of
the overall market. High cost of automated HIV
diagnosis procedures and lack of skilled
professionals are some of the key factors
restraining the growth of global HIV diagnosis
market.
4
Global HIV Diagnosis Market
Insights on market segments
As per the findings of the research, based on
products, consumables segment is the largest
product category in the global HIV diagnosis
market. Antibody test has been the largely
performed test of the global HIV diagnosis
market, followed by viral load, CD4, early infant
diagnosis and viral identification. Diagnostic
laboratories have been the largest end user of
HIV diagnosis, followed by hospitals, research
institutes and others.
5
Global HIV Diagnosis Market
North America stands as the largest HIV diagnosis
market
Geographically, North America has been the
largest market for HIV diagnosis, with the U.S.
being the largest contributor to the regional
market. Increasing prevalence of HIV/AIDS and
advantageous features of point of care
instruments and kits have been driving the growth
of the North American market. In Europe, the U.K.
has been the largest contributor to the market
for HIV diagnosis, followed by Germany and
France. The HIV diagnosis market is expected to
witness the fastest growth in Asia-Pacific,
during 2017 - 2023, owing to increasing cases of
HIV, rising healthcare expenditure and increasing
frequency of blood transfusions.
6
Global HIV Diagnosis Market
Increasing healthcare expenditure on HIV and
related activites largely impacts the market
The healthcare expenditure for the purpose of
alleviating the potential epidemic situation of
HIV, has increased over the past few years in
many low and middle income as well as developing
countries. According to the data published by
UNAIDS, 19.0 billion was spent on the HIV and
AIDS related activities in low- and middle-income
countries in 2015, of which 57 came from
domestic budgets of the governments of these
countries. Considering the increasing incidence
of HIV, the UNAIDS estimated that approximately
26.2 billion will be required to respond to the
epidemic of HIV infection expected in 2020 and
around 23.9 billion will be required for the
same, in 2030. The variation in healthcare
spending across regions is thought to be related
to the relative burden of the disease in that
region, which in case of Sub-Saharan Africa is
significantly high. The overall healthcare
spending on HIV and related activities has
increased over the years, which in turn is
expected to drive the growth of the global HIV
diagnosis market.
7
Global HIV Diagnosis Market
Increase in the popularity of home-based HIV
diagnosis devices present opportunity to the
players in HIV diagnosis market
In recent years the USFDA has approved some
home-based HIV diagnosis kits that can provide a
HIV test result within 20 to 40 minutes, without
having the need for sending the test sample to a
laboratory. The home-based HIV diagnosis devices
offer a number of advantages over the standard
HIV diagnosis procedure since they are more
convenient to use, save time and are less costly
which has made them increasingly popular in
countries such as the U.S. and the U.K. The
availability of the home-based tests is expected
to contribute significantly in helping more
infected people become aware of their HIV status
and thereby tapping the untapped potential of HIV
diagnosis market. Some of the home-based kits
approved by the USFDA include Home Access HIV-1
Test System and OraQuick In-Home HIV Test. This
provides an opportunity to the players to further
strengthen their current and potential markets,
launching low-cost and easy to use HIV diagnosis
devices that can be used at home by the consumers.
8
Global HIV Diagnosis Market
Key players in the HIV diagnosis market
Some of the key players in the global HIV
diagnosis market include Siemens AG, F. Hoffman
La Roche Ltd., Danaher Corporation, Abbott
Laboratories, Ltd., Thermo-Fisher Scientific
Inc., Merck KGaA, Becton, Dickinson Company,
Alere Inc., Bio-Rad Laboratories and Hologic Inc.
9
Global HIV Diagnosis Market
Download report sample at
https//www.psmarketresearch.com/market-analysis/h
iv-diagnosis-market/report-sample
10
GET IN TOUCH
THANK YOU!
For information regarding permissions and other
queries Kindly write to
US/Canada Toll-Free 1-888-778-7886